Intensity (INTS) IPO deck updated Intensity Therapeutics (INTS) is engaged in the discovery and development of cancer drugs. Debarshi Ghosh 26 Sep 2022 Share on Twitter Share on Facebook Share on LinkedIn Share on Pinterest Share via Email Copy link IPO Debarshi Ghosh IPO Candy Newsletter Join the newsletter to receive the latest updates in your inbox. Your email address Subscribe Please check your inbox and click the link to confirm your subscription. Please enter a valid email address! An error occurred, please try again later.